Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Experience the Drillmore difference| Babak Bemani , Chief Executive Officer at Drillmore
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Babak Bemani is a CEO & Founder of Bit Azin and Drillmore Canada
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Al Etihad Gold Refinery's Sonia Vara Highlights High Standards and Global Accreditations at Industry Event
00:10:00
Seeks total return | Christopher Kelliher,Fund Manager,Fidelity Advisor Risk Parity Fund
00:10:00
“Convegno di Primavera: George Muzinich on Complementary Pension Systems and Economic Impact Amidst New Regulations” | George Muzinich
00:00:00
Albert Friessen, Chair & CEO, Medicure Inc.
00:10:00
Ben Minicucci's 90th Anniversary Message to Alaska Airlines Employees | Ben Minicucci, CEO, Alaska Airlines .
00:10:00
Strategic Exploration: High-Grade Gold Potential in Washington's Republic District
00:10:00
Cargotec's CEO Mika Vehviläinen provides a review of the year 2022, with further details on the company's business areas
00:10:00
"Genevieve Piche: Leading ESG Solutions at Wells Fargo Corporate & Investment Bank - Insights from the Managing Director and Head of ESG Solutions"
00:10:00
Sandstorm Gold President and CEO Nolan Watson discusses company updates, while Remark Holdings, Inc. (NASDAQ: MARK) shares market insights.
00:10:00
Today's Featured Stock (200421) - Daeati Co Ltd | Jin-Woo CHOI, CEO, DaeaTI Co Ltd4539K:KOE
00:10:00
Exclusive: Belden's CEO Ashish Chand Talks Strategy with BW Businessworld | Ashish Chand - CEO of Belden Incorporated
00:00:00
EnterNext welcomes Abivax on Euronext in Paris - Dr. Hartmut Ehrlich, CEO, Abivax